Pharmaceuticals, Biotechnology and Life Sciences
Health authorities in major European countries have accepted the reclassification of JNJ-1900 (NBTXR3) from a medical device to a medicinal…
Los Angeles, CA , July 07, 2025 (GLOBE NEWSWIRE) — Luma Nutrition is proud to announce that its flagship product,…
Potential Distribution Range of $0.04 to $0.08 per share of outstanding stock based on current estimates and assumptions, including timely…
CAMBRIDGE, Mass., July 07, 2025 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible…
COPENHAGEN, Denmark, July 07, 2025 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced two oral presentations at ENDO…
SHELTON, Conn., July 06, 2025 (GLOBE NEWSWIRE) — Abinopharm, Inc., an innovative nutritional and biopharmaceutical company based in Shelton, Connecticut,…
Webcast to be held Monday, July 7th at 8:00 a.m. ETSAN FRANCISCO and BOSTON, July 06, 2025 (GLOBE NEWSWIRE) —…
Luxembourg (July 3, 2025) – Alvotech S.A. announces that on June 25, 2025, the proportion of own shares held by…
MONTREAL, July 03, 2025 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical…
RESEARCH TRIANGLE PARK, N.C., July 03, 2025 (GLOBE NEWSWIRE) — Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing…